Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Stellaris Health Network has signed a contract with Medical Information Technology Inc. (Meditech) to deploy its Client/Server Health Care Information System (HCIS) across Stellaris' four-hospital organization.
Digital imaging and telemedicine applications provider Trestle Holdings Inc. will deploy its live microscopy product, MedMirco, at the University of Michigan Health System (UMHS).
PACS administrators are making, on average, $60,000 to $65,000, according to the PACS Administrator Salary Survey just published in the April issue of Health Imaging & IT magazine.
Siemens Medical Solutions USA Inc. is partnering with group purchasing organization (GPO) Premier Inc. on a 90-day group buy initiative for the company's MRI systems.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
